Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
APOBEC1 encodes a member of the cytidine deaminase enzyme family. Zusätzlich bieten wir Ihnen APOBEC1 Proteine (7) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 58 products:
Mouse (Murine) Polyclonal APOBEC1 Primary Antibody für ELISA, WB - ABIN449571
Lau, Chan: Involvement of a chaperone regulator, Bcl2-associated athanogene-4, in apolipoprotein B mRNA editing. in The Journal of biological chemistry 2003
Luciferase-fused 3' untranslated region of human Dickkopf1 (zeige DKK1 Antikörper) activity was highly upregulated in A1CF (zeige A1CF Antikörper)-overexpressed MCF7 cells, but this upregulation can be inhibited by mutating conserved binding motifs of Dickkopf1 (zeige DKK1 Antikörper) 3' untranslated region. A1CF (zeige A1CF Antikörper) played a crucial role in cell migration and survival through affecting 3' untranslated region of Dickkopf1 (zeige DKK1 Antikörper) to upregulate its expression in MCF7 cells.
AICDA (zeige AICDA Antikörper)/APOBEC family of cytidine deaminases is significant in innate immunity, as it restricts numerous viruses, including HBV, through hypermutationdependent and independent mechanisms. (Review)
Results show that expression of APOBEC1 induces a mutator phenotype in 2 different cellular models.
hnRNPQ6 is required for APOBEC1-enhanced IL8 (zeige IL8 Antikörper) production.
Studies indicate the APOBEC family consists of 11 members: APOBEC-1 (Apo1), APOBEC-2 (Apo2), activation induced cytidine deaminase (AID), APOBEC- 3A, -3B, -3C, -3DE, -3F, -3H (Apo3A-H) and APOBEC- 4 (Apo4).
The hypermutation activity of APOBEC-1 was decreased to background levels by a single point APOBEC-1 mutation of P29F or E181Q, while 50% of wild-type control editing at the normal site was retained.
The data presented in this report suggested that similar regulatory mechanisms controlling the functional interaction of APOBEC-1 with ACF (zeige A1CF Antikörper) might be operational during enterocyte differentiation.
Identified two novel variants, rs1349411 (APOBEC1) and rs1424032, for serum apoB (zeige APOB Antikörper) levels in Mexicans.
C-->U editing of neurofibromatosis 1 (zeige NF1 Antikörper) mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B (zeige APOB Antikörper) mRNA-editing enzyme
expression of two proteins essential for apolipoprotein B (zeige APOB Antikörper) mRNA editing from a single gene through alternative splicing
substantial rearrangement/duplication of transgene elements is present, and transgene integration was accompanied by the deletion of a 19,500 bp fragment of genomic DNA that contains the promoter, exon 1 and part of intron 1 of the APOBEC1 complementation factor (A1cf (zeige A1CF Antikörper)) gene, as well as several elements that are predicted to regulate chromosomal architecture
The observations demonstrate that A1CF (zeige A1CF Antikörper) does not act as the APOBEC1 complementation factor (zeige A1CF Antikörper) in vivo under normal physiological conditions and suggest new roles for A1CF (zeige A1CF Antikörper), specifically within the male adult kidney.
Apobec-1-dependent C-to-U RNA editing exerts broad functional effects in a tissue-specific manner.
RBM47 and APOBEC1 constitute the basic machinery for C to U RNA editing.
In contrast to in vitro results, APOBEC1 neither inhibited nor significantly drove the molecular evolution of Friend retrovirus in wild type or APOBEC1 knockout mice.
Individual genetic variability at the Apobec1 locus results in differential rates of C-to-U(T) editing in murine macrophages; with mouse strains expressing mostly a truncated alternative transcript isoform of Apobec1 exhibiting lower rates of editing.
The transgenic rescue of intestinal apobec-1 expression restores C-to-U RNA editing of apoB (zeige APOB Antikörper) mRNA in vivo, including the canonical site at position 6666 and also at approximately 20 other newly identified downstream sites present in WT mice.
Results suggest that apo (zeige C9orf3 Antikörper) B mRNA editing protein (Apobec1 cytidine deaminase (zeige CDA Antikörper)) plays a central role in controlling testicular germ cell tumors susceptibility in both a conventional and a transgenerational manner.
The transcriptomics approach to RNA editing presented in this study dramatically expands the list of APOBEC1 mRNA editing targets and reveals a novel cellular mechanism for the modification of transcript 3' UTRs.
LDL receptor (zeige LDLR Antikörper) and the apolipoprotein B (zeige APOB Antikörper) mRNA editing enzyme Apobec1 are regulated via calcium signaling in mechanistic response to genetic, mechanical, and environmental insults that trigger an imbalance of intracellular calcium homeostasis
A moderate reduction of the APOBEC1 dependent editing induces a lean phenotype at least in the rabbit species.
This gene encodes a member of the cytidine deaminase enzyme family. The encoded protein forms a multiple-protein editing holoenzyme with APOBEC1 complementation factor (ACF) and APOBEC1 stimulating protein (ASP). This holoenzyme is involved in the editing of C-to-U nucleotide bases in apolipoprotein B and neurofibromatosis-1 mRNAs.
C->U-editing enzyme APOBEC-1
, apolipoprotein B mRNA editing enzyme complex-1
, apolipoprotein B mRNA-editing enzyme 1
, apolipoprotein B editing complex 1
, Apolipoprotein B editing protein
, apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
, apolipoprotein B mRNA editing enzyme complex 1
, apolipoprotein B mRNA editing protein
, APOBEC1 complementation factor
, apobec-1 complementation factor
, APOBEC1-stimulating protein
, apobec-1 complementation factor-like
, APOBEC1 complementation factor-like
, Apolipoprotein B mRNA-editing enzyme 1
, apolipoprotein B mRNA editing catalytic subunit-1